GT Biopharma (GTBP) Minority Interest (2012 - 2021)
GT Biopharma (GTBP) posted quarterly Minority Interest of -$169000.0 for Q1 2021, little changed year-over-year from -$169000.0 in Q1 2020, and little changed quarter-over-quarter from -$169000.0 in Q4 2020.
GT Biopharma (GTBP) Minority Interest (2012 - 2021) Analysis & Trends
GT Biopharma (GTBP) has reported Minority Interest for 10 consecutive years, with -$169000.0 the latest figure, recorded in Q1 2021.
- In Q1 2021, Minority Interest changed 0.0% year-over-year to -$169000.0; the TTM figure through Mar 2021 stood at -$169000.0 (changed 0.0% YoY), while the FY2020 annual figure was -$169000.0, changed 0.0% from the prior year.
- Minority Interest was little changed at -$169000.0 in Q1 2021 per GTBP's latest filing, from -$169000.0 in the prior quarter.
- Across five years, Minority Interest topped out at -$169000.0 in Q4 2017 and bottomed at -$169000.0 in Q4 2017.
- Historically, Minority Interest has averaged -$169000.0 across 5 years, with a median of -$169000.0 in 2017.
- On a YoY basis, Minority Interest climbed as much as 0.0% in 2017 and fell as far as 0.0% in 2017.
- GT Biopharma's Minority Interest stood at -$169000.0 in 2017, then changed by 0.0% to -$169000.0 in 2018, then changed by 0.0% to -$169000.0 in 2019, then changed by 0.0% to -$169000.0 in 2020, then changed by 0.0% to -$169000.0 in 2021.
- Business Quant data shows GTBP's Minority Interest at -$169000.0 in Q1 2021, -$169000.0 in Q4 2020, and -$169000.0 in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | GT Biopharma | 8.64 Mn | 8.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | -169,000.00 |
| Dec 31, 2020 | -169,000.00 |
| Sep 30, 2020 | -169,000.00 |
| Jun 30, 2020 | -169,000.00 |
| Mar 31, 2020 | -169,000.00 |
| Dec 31, 2019 | -169,000.00 |
| Sep 30, 2019 | -169,000.00 |
| Jun 30, 2019 | -169,000.00 |
| Mar 31, 2019 | -169,000.00 |
| Dec 31, 2018 | -169,000.00 |
| Sep 30, 2018 | -169,000.00 |
| Jun 30, 2018 | -169,000.00 |
| Mar 31, 2018 | -169,000.00 |
| Dec 31, 2017 | -169,000.00 |
| Dec 31, 2016 | -169,000.00 |
| Jun 30, 2016 | -169,000.00 |
| Mar 31, 2016 | -169,000.00 |
| Dec 31, 2015 | -169,000.00 |
| Dec 31, 2014 | -169,000.00 |
| Mar 31, 2014 | -153,000.00 |